Skip to main content
. 2015 Feb 6;9:4. doi: 10.3389/fnsys.2015.00004

Figure 1.

Figure 1

Using differential signaling pathway activation profiles between cell/tissue culture or mice treated and untreated with known cognitive modulators or genetic models of cognitive enhancement to screen for potential nootropic compounds.